Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Hematol Oncol. 2023 Apr 22;41(4):743–752. doi: 10.1002/hon.3159

Figure 1.

Figure 1.

Swimmer plot of best treatment response and survival for all patients since the first dose of study drug. Each lane represents one patient in the study, with the colored bars indicating the drug exposure. The numbers on the left indicate the treatment cohort each patient was a part of: 1, Ven 400 Alvo 45 “no ramp-up”; 2, Ven 400 Alvo 45; 3, Ven 400 Alvo 60. 4, Ven 600 Alvo 60. 5, Ven 800 Alvo 60. Note: #, prior venetoclax.